Clinical & Payment Policies | Ambetter de Arkansas Health & Wellness

 

Políticas clínicas y de pago

To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number or effective date.

What are Clinical Policies?

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include policies relating to evolving medical technologies and procedures as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice, including peer-reviewed medical literature, government agency/program approval status, evidence-based guidelines, positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas affected by the policy, and other available clinical information. 

All policies found in the Arkansas Health & Wellness Clinical Policy Manual apply to Arkansas Health & Wellness members. Policies in the Arkansas Health & Wellness Clinical Policy Manual may have either an “Arkansas Health & Wellness” or a “Centene” heading.  Arkansas Health & Wellness utilizes InterQual® criteria for those medical technologies, procedures, or pharmaceutical treatments for which an Arkansas Health & Wellness clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual SmartSheets™ for adult and pediatric procedures, durable medical equipment, and imaging procedures by logging in to our Secure Provider Portal or calling Arkansas Health & Wellness at 1-877-617-0390 (TTY 1-877-617-0392).

Arkansas Health & Wellness may, from time to time, delegate utilization management of specific services. In such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the Clinical Policy Manuals or InterQual criteria is payable by Arkansas Health & Wellness.

What are Payment Policies?

Healthcare claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include claims processing guidelines referenced by the Centers for Medicare & Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), CPT® guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of healthcare and medical necessity, and, at times, state-specific claims reimbursement
guidance.

All policies found in the Arkansas Health & Wellness Payment Policy Manual apply with respect to Arkansas Health & Wellness members. Policies in the Arkansas Health & Wellness Payment Policy Manual may have either an “Arkansas Health & Wellness” or a “Centene” heading. Arkansas Health & Wellness may, from time-to-time, employ a vendor that applies payment policies to specific services. In such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the Payment Policy Manual is payable by Arkansas Health & Wellness. 

Prior Authorization Requests

Ambetter from Arkansas Health and Wellness will be partnering with Evolent for prior authorization requests for the following services:

  • Physical Therapy
  • Occupational Therapy
  • Speech Therapy
  • Spinal Epidural Injections
  • Paravertebral Facet Joint Injections or Blocks
  • Paravertebral Facet Joint Denervation (Radiofrequency Neurolysis)
  • Sacroiliac Joint Injections

Clinical Policies for these procedures can be found at the http://www.radmd.com/.

Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet Scans can also be found at the http://www.radmd.com/.

Clinical policies for musculoskeletal procedures can be found on the Turning point website at http://www.myturningpoint-healthcare.com/

Policy TitlePolicy NumberEffective Date
Acupuncture (PDF)CP.MP.92August 1, 2024
Air Ambulance (PDF)CP.MP.175July 1, 2024
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF)CP.MP.108October, 1 2024
Applied Behavior Analysis (PDF)CP.BH.104June 1, 2024
Applied Behavioral Analysis Documentation Requirements (PDF)CP.BH.105May 1, 2024
Articular Cartilage Defect Repairs (PDF)CP.MP.26April 1, 2024
Assisted Reproductive Technology (PDF)CP.MP.55March 1, 2024
Behavioral Health Treatment Documentation Requirements (PDF)HIM.CP.BH.500July 1, 2024
Biofeedback (PDF)CP.MP.168January 1, 2024
Biofeedback for Behavioral Health Disorders (PDF)CP.BH.300May 1, 2023
Bone-Anchored Hearing Aids (PDF)AR.CP.MP.93August 1, 2023
Burn Surgery (PDF)CP.MP.186April 1, 2024
Caudal or Interlaminar Epidural Steroid Injections (PDF)CP.MP.164August 1, 2024
Clinical Trials (PDF)CP.MP.94August 1, 2024
Cochlear Implanted Replacements (PDF)AR.CP.MP.14September 1, 2024
Concert Genetics Oncology: Algorithmic Testing (PDF)V2.2024September 1, 2024
Concert Genetics Oncology: Cancer Screening (PDF)V2.2024September 1, 2024
Concert Genetics Oncology: Circulating Tumor DNA and Circulating
Tumor Cells (Liquid Biopsy) (PDF)
V2.2024September 1, 2024
Concert Genetics Oncology: Cytogenetic Testing (PDF)V2.2024September 1, 2024
Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Cardiac Disorders (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Dermatologic Conditions (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Disorders (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Eye Disorders (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: General Approach to Genetic and Molecular Testing (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Hearing Loss (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Kidney Disorders (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Lung Disorders (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Non-invasive Prenatal Screening (NIPS) (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Pharmacogenetics (PDF)V2.2024
September 1, 2024
Concert Genetic Testing: Preimplantation Genetic Testing (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)V2.2024September 1, 2024
Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)V2.2024September 1, 2024
Cosmetic and Reconstructive Procedures (PDF)CP.MP.31October, 1 2024
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF)CP.BH.201August 1, 2024
Diaphragmatic/Phrenic Nerve Stimulation (PDF)CP.MP.203September 1, 2024
Disc Decompression Procedures (PDF)CP.MP.114October, 1 2024
Discography (PDF)CP.MP.115July 1, 2024
Donor Lymphocyte Infusion (PDF)CP.MP.101June 1, 2024
Durable Medical Equipment and Orthotics and Prosthetics Guidelines (PDF)CP.MP.107October, 1 2024
Electric Tumor Treating Fields (Optune) (PDF)CP.MP.145January 1, 2024
Experimental Technologies (PDF)CP.MP.36June 1, 2024
Facet Joint Interventions (PDF)CP.MP.171November 1, 2024
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF)CP.MP.248June 1, 2024
Fecal Incontinence Treatments (PDF)CP.MP.137August 1, 2024
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF)CP.MP.129November 1, 2024
Fertility Preservation (PDF)CP.MP.130March 1, 2024
Functional MRI (PDF)CP.MP.43April 1, 2024
Gastric Electrical Stimulation (PDF)CP.MP.40July 1, 2024
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF)CP.MP.209August 1, 2023
Gender-Affirming Procedures (PDF)CP.MP.95
September 1, 2024
Heart-Lung Transplant (PDF)CP.MP.132July 1, 2024
Home Births (PDF)CP.MP.136March 1, 2024
Home Ventilators (PDF)CP.MP.184October, 1 2024
Hospice Services (PDF)CP.MP.54November 1, 2024
Hyperhidrosis Treatments (PDF)CP.MP.62June 1, 2024
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF)CP.MP.180January 1, 2024
Implantable Intrathecal or Epidural Pain Pump (PDF)CP.MP.173June 1, 2024
Implantable Loop Recorder (PDF)CP.MP.243June 1, 2024
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF)CP.MP.160June 1, 2024
Intensity-Modulated Radiotherapy (PDF)CP.MP.69September 1, 2024
Intestinal and Multivisceral Transplant (PDF)CP.MP.58July 1, 2024
Intradiscal Steroid Injections for Pain Management (PDF)CP.MP.167September 1, 2024
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF)CP.MP.61October, 1 2024
Lantidra (donislecel): Allogeneic Pancreatic Islet Cellular Therapy(PDF)CP.MP.250September 1, 2024
Liposuction for Lipedema (PDF)CP.MP.244July 1, 2024
Long Term Care Placement (PDF)CP.MP.71April 1, 2024
Lung Transplantation (PDF)CP.MP.57June 1, 2024
Lysis of Epidural Lesions (PDF)CP.MP.116July 1, 2024
Mechanical Stretching Devices for Joint Stiffness and Contracture (PDF)CP.MP.144December 1, 2024
Multiple Sleep Latency Testing (PDF)CP.MP.24July 1, 2024
Neonatal Abstinence Syndrome Guidelines (PDF)CP.MP.86March 1, 2024
Neonatal Sepsis Management (PDF)CP.MP.85March 1, 2024
Nerve Blocks and Neurolysis for Pain Management (PDF)CP.MP.170June 1, 2024
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF)CP.MP.48August 1, 2024
NICU Apnea Bradycardia Guidelines (PDF)CP.MP.82March 1, 2024
NICU Discharge Guidelines (PDF)CP.MP.81March 1, 2024
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF)CP.MP.141July 1, 2024
Obstetrical Home Care Programs (PDF)CP.MP.91July 1, 2024
Omisirge (omidubicel): Nicotinamide-Modified Allogeneic Hematopoietic Progenitor Cell Therapy (PDF)CP.MP.249August 1, 2024
Orthognathic Surgery (PDF)CP.MP.202 October, 1 2024
Osteogenic Stimulation (PDF)CP.MP.194September 1, 2024
Outpatient Cardiac Rehabilitation (PDF)CP.MP.176September 1, 2024
Outpatient Oxygen Use (PDF)CP.MP.190June 1, 2024
Pancreas Transplantation (PDF)CP.MP.102April 1, 2024
Panniculectomy (PDF)CP.MP.109October, 1 2024
Pediatric Heart Transplant (PDF)CP.MP.138October, 1 2024
Pediatric Kidney Transplant (PDF)CP.MP.246June 1, 2024
Pediatric Liver Transplant (PDF)CP.MP.120July 1, 2024
Pediatric Oral Function Therapy (PDF)CP.MP.188July 1, 2024
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)CP.MP.147July 1, 2024
Phototherapy for Neonatal Hyperbilirubinemia (PDF)CP.MP.150October, 1 2024
Physical, Occupational, and Speech Therapy Services (PDF)CP.MP.49August 1, 2024
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF)CP.MP.133September 1, 2024
Proton and Neutron Beam Therapies (PDF)CP.MP.70January 1, 2024
Reduction Mammoplasty and Gynecomastia Surgery (PDF)CP.MP.51November 1, 2024
Repair of Nasal Valve Compromise (PDF)CP.MP.210July 1, 2024
Sacroiliac Joint Fusion (PDF)CP.MP.126October, 1 2024
Sacroiliac Joint Interventions for Pain Management (PDF)CP.MP.166September 1, 2024
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF)CP.MP.146September 1, 2024
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF)CP.MP.174January 1, 2024
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF)CP.MP.165September 1, 2024
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF)CP.MP.185August 1, 2024
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)CP.MP.117October, 1 2024
Stereotactic Body Radiation Therapy (PDF)CP.MP.22December 1, 2024
Tandem Transplant (PDF)CP.MP.162April 1, 2024
Therapeutic Utilization of Inhaled Nitric Oxide (PDF)CP.MP.87September 1, 2024
Total Artificial Heart (PDF)CP.MP.127August 1, 2024
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)CP.MP.163April 1, 2024
Transplant Service Documentation Requirements (PDF)CP.MP.247December 1, 2024
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF)CP.BH.200August 1, 2024
Trigger Point Injections for Pain Management (PDF)CP.MP.169September 1, 2024
Urinary Incontinence Devices and Treatments (PDF)CP.MP.142January 1, 2024
Vagus Nerve Stimulation (PDF)CP.MP.12September 1, 2024
Ventricular Assist Devices (PDF)CP.MP.46April 1, 2024

Policy TitlePolicy NumberEffective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF)CP.MP.157 November 1, 2024
3-Day Payment Window (PDF)CC.PP.500July 1, 2014
Add-On Code Billed Without Primary Code (PDF)CC.PP.030October 18, 2016
Allergy Testing and Therapy (PDF)CP.MP.100November 1, 2024
Ambulatory EEG (PDF)CP.MP.96August 12, 2016
Assistant Surgeon (PDF)CC.PP.029February 7, 2017
Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF)CP.BH.124December 1, 2024
Bilateral Procedures (PDF)CC.PP.037February 7, 2017
Bronchial Thermoplasty (PDF)CP.MP.110November 1, 2024
Cardiac Biomarker Testing (PDF)CP.MP.156 November 1, 2024
Cerumen Removal (PDF)CC.PP.008August 12, 2016
Clean Claims (PDF)CC.PP.021October 18, 2016
Coding Overview (PDF)CC.PP.011October 18, 2016
Cosmetic Procedures (PDF)CC.PP.024October 18, 2016
Digital EEG Spike Analysis (PDF)CP.MP.105November 1, 2024
Distinct Procedural Modifiers (PDF)CC.PP.020October 18, 2016
Drugs of Abuse: Definitive Testing (PDF)CP.MP.50 November 1, 2024
Duplicate Primary Code Billing (PDF)CC.PP.044February 7, 2017
EEG in the Evaluation of Headache (PDF)CP.MP.155November 1, 2024
E&M Medical Decision-Making (PDF)CC.PP.051July 25, 2017
EM Bundling Edits (PDF)CC.PP.010August 12, 2016
Endometrial Ablation (PDF)CP.MP.106November 1, 2024
Evoked Potential Testing (PDF)CP.MP.134November 1, 2024
Global Maternity Billing (PDF)CC.PP.016October 18, 2016
Helicobacter Pylori Serology Testing (PDF)CP.MP.153November 1, 2024
Holter Monitors (PDF)CP.MP.113June 1, 2024
Homocysteine Testing (PDF)CP.MP.121May 1, 2023
Hospital Visit Codes Billed with Labs (PDF)CC.PP.023October 18, 2016
Inpatient Consultation (PDF)CC.PP.038February 7, 2017
Inpatient Only Procedures (PDF)MP.PP.018April 1, 2024
IV Hydration (PDF)CC.PP.012October 18, 2016
Laser Therapy for Skin Conditions (PDF)CP.MP.123November 1, 2024
Leveling of Care: Evaluation and Management Overcoding (PDF)CC.PP.066March 15, 2021
Leveling of Emergency Room (PDF)CC.PP.053 January 1, 2019
Low-frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF)CP.MP.139November 1, 2024
Maximum Units (PDF)CC.PP.007August 12, 2016
Measurement of Serum 1,25-dihydroxyvitamin D (PDF)CP.MP.152November 1, 2024
Moderate Conscious Sedation (PDF)CC.PP.015October 18, 2016
Modifier -25 clinical validation (PDF)CC.PP.013October 18, 2016
Modifier -59 clinical validation (PDF)CC.PP.014October 18, 2016
Modifier DOS Validation (PDF)CC.PP.034October 18, 2016
Modifier to Procedure Code Validation (PDF)CC.PP.028October 18, 2016
Multiple CPT Code Replacement (PDF)CC.PP.033October 18, 2016
Multiple Diagnostic Cardiovascular Procedure Payment Reduction (PDF)CC.PP.065March 15, 2021
Multiple Procedure Reduction: Ophthalmology (PDF)CC.PP.069March 15, 2021
Multiple Procedure Payment Reduction for Therapeutic Services (PDF)CC.PP.068March 15, 2021
NCCI Unbundling (PDF)CC.PP.031October 18, 2016
Never Paid Events (PDF)CC.PP.017October 18, 2016
New Patient (PDF)CC.PP.036February 7, 2017
Non-Obstetrical Pelvic and Transabdominal Ultrasound (PDF)CC.PP.061 March 15, 2021
Outpatient Consultation (PDF)CC.PP.039February 7, 2017
Physician’s Consultation Services (PDF)CC.PP.054September 1, 2018
Physician Visit Codes Billed with Labs (PDF)CC.PP.019October 18, 2016
Place of Service Mismatch (PDF)CC.PP.063 December 15, 2018
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF)CP.MP.181 November 1, 2024
Post-Operative Visits (PDF)CC.PP.042February 7, 2017
Pre-Operative Visits (PDF)CC.PP.041February 7, 2017
Problem Oriented Visits with Preventative Services (PDF)CC.PP.057November 1, 2018
Problem Oriented Visits with Surgical Procedures (PDF)CC.PP.052November 1, 2018
Professional Component (PDF)CC.PP.027October 18, 2016
Pulmonary Function Testing (PDF)CP.MP.242November 1, 2024
Pulse Oximetry (PDF)CC.PP.025October 18, 2016
Renal Hemodialysis (PDF)CC.PP.067March 15, 2021
Robotic Surgery (PDF)CC.PP.050November 1, 2017
Same Day Visits (PDF)CC.PP.040February 7, 2017
Skilled Nursing Facility Leveling (PDF)CC.PP.206October, 1 2024
Status "B" Bundled Services (PDF)CC.PP.046February 7, 2017
Status P Bundled Services (PDF)CC.PP.049June 17, 2017
Supplies Billed on Same Day As Surgery (PDF)CC.PP.032October 18, 2016
Testing for Select Genitourinary Conditions (PDF)CP.MP.97June 1, 2024
Thyroid Hormones and Insulin Testing in Pediatrics (PDF)CP.MP.154November 1, 2024
Transgender Related Services (PDF)CC.PP.047February 22, 2017
Ultrasound in Pregnancy (PDF)CP.MP.38November 1, 2024
Unbundled Professional Services (PDF)CC.PP.043April 6, 2017
Unbundled Surgical Procedures (PDF)CC.PP.045April 6, 2017
Unlisted Procedure Codes (PDF)CC.PP.009August 12, 2016
Urine Specimen Validity Testing (PDF)CC.PP.056November 8, 2017
Urodynamic Testing (PDF)CP.MP.98November 1, 2024
Wheelchair Accessories (PDF)CC.PP.502August 12, 2016
Wheelchair Seating (PDF)CP.MP.99November 1, 2024
Wireless Motility Capsule (PDF)CP.MP.143November 1, 2024

Policy TitlePolicy NumberEffective Date
Abaloparatide (Tymlos) (PDF)CP.PHAR.345February 1, 2024
Abametapir (Xeglyze) (PDF)CP.PMN.253Retire by January 1, 2025
Abatacept (Orencia)CP.PHAR.241July 1, 2024
Abemaciclib (Verzenio) (PDF)CP.PHAR.355January 1, 2025
Abiraterone (Zytiga) (PDF)CP.PHAR.84April 1, 2024
AbobotulinumtoxinA (Dysport) (PDF)CP.PHAR.230July 1, 2024
Abrocitinib (Cibinqo) (PDF)CP.PHAR.578September 1, 2024
Acalabrutinib (Calquence)CP.PHAR.366February 1, 2024
Acyclovir Buccal tab (Sitavig) (PDF)CP.PMN.210January 1, 2025
Adagrasib (Krazati) (PDF)CP.PHAR.605September 1, 2024
ADAMTS13, recombinant-krhn (Adzynma) (PDF)CP.PHAR.635August 1, 2024
Adefovir (Hepsera) (PDF)CP.PHAR.142January 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF)CP.PHAR.229June 1, 2024
Aducanumab (Aduhelm) (PDF)CP.PHAR.468June 1, 2024
Afamelanotide (Scenesse) (PDF)CP.PHAR.444February 1, 2024
Afamitresgene Autoleucel (ADP-A2M4) (PDF)CP.PHAR.678  Retire by January 1, 2025
Afatinib (Gilotrif) (PDF)CP.PHAR.298June 1, 2023
Aflibercept (Eylea) (PDF)CP.PHAR.184November 1, 2024
Agalsidase Beta (Fabrazyme) (PDF)CP.PHAR.158July 1, 2024
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF)CP.PMN.138June 1, 2024
Alectinib (Alecensa) (PDF)CP.PHAR.369July 1, 2024
Alemtuzumab (Lemtrada) (PDF)CP.PHAR.243June 1, 2024
Alendronate (Binosto, Fosamax plus D) (PDF)CP.PMN.88February 1, 2024
Alglucosidase (Lumizyme) (PDF)CP.PHAR.160July 1, 2024
Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (PDF)CP.PHAR.562February 1, 2024
Allogenic processed thymus tissue-agdc (Rethymic) (PDF)CP.PHAR.563February 1, 2024
Alpelisib (Piqray) (PDF)CP.PHAR.430September 1, 2024
Alpha-1 Proteinase Inhibitors (Aralast® NP, Glassia®, Prolastin-C®, Zemaira®) (PDF)CP.PHAR.94February 1, 2024
Amantadine ER (Gocovri,Osmolex ER) (PDF)CP.PMN.89February 1, 2024
Ambrisentan (Letairis®) (PDF)CP.PHAR.190February 1, 2024
Amifampridine (Firdapse)(PDF)CP.PHAR.411April 1, 2024
Amikacin (Arikayce)(PDF) CP.PHAR.401September 1, 2024
Amisulpride (Barhemsys)(PDF)CP.PMN.236October 1, 2024
Amivantamab-vmjw (Rybrevant) (PDF)CP.PHAR.544January 1, 2025
Amivantamab-vmjw (Rybrevant) (PDF)CP.PHAR.544Retire by January 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF)CP.PHAR.551March 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF)CP.PHAR.551Retire by March 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)CP.PHAR.217February 1, 2024
Antithymocyte Globulin (Thymoglobulin, Atgam) (PDF)CP.PHAR.506January 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF)CP.PHAR.564February 1, 2024
Apalutamide (Erleada) (PDF)CP.PCH.45July 1, 2024
Apomorphine (Apokyn) (PDF)CP.PHAR.488September 1, 2024
Aprepitant (Emend®) (PDF)CP.PMN.19September 1, 2024
Aprocitentan (Tryvio) (PDF)CP.PHAR.676June 1, 2024
Aripiprazole Long-Acting Injections (Abilify Maintena, Aristada) (PDF)CP.PHAR.290September 1, 2024
Aripiprazole ODT (Abilify) (PDF)CP.PCH.37September 1, 2024
Armodafinil (Nuvigil) (PDF)CP.PMN.35June 1, 2024
Asciminib (Scemblix) (PDF)CP.PHAR.565October 1, 2024
Asenapine (Saphris) (PDF)CP.PMN.15January 1, 2025
Asenapine (Saphris) (PDF)CP.PMN.15Retire by January 1, 2025
Asfotase Alfa (Strensiq) (PDF)CP.PHAR.328January 1, 2025
Asfotase Alfa (Strensiq) (PDF)CP.PHAR.328Retire by January 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF)CP.PMN.20February 1, 2024
Atezolizumab (Tecentriq) (PDF)CP.PHAR.235April 1, 2024
Atidarsagene autotemcel (OTL-200) (PDF)CP.PHAR.602September 1, 2024
Atogepant (Qulipta) (PDF)CP.PHAR.566March 1, 2025
Atogepant (Qulipta) (PDF)CP.PHAR.566Retire by March 1, 2025
Avacopan (Tavneos) (PDF)CP.PHAR.515February 1, 2024
Avacincaptad pegol (Izervay) (PDF)CP.PHAR.641March 1, 2025
Avacincaptad pegol (Izervay) (PDF)CP.PHAR.641Retire by March 1, 2025
Avalglucosidase alfa-ngpt (Nexviazyme) (PDF)CP.PHAR.521July 1, 2024
Avapritinib (Ayvakit) (PDF)CP.PHAR.454February 1, 2024
Avatrombopag (Doptelet) (PDF)CP.PHAR.130March 1, 2025
Avatrombopag (Doptelet) (PDF)CP.PHAR.130Retire by March 1, 2025
Avelumab (Bavencio) (PDF)CP.PHAR.333February 1, 2024
Axatilimab-csfr (Niktimvo) (PDF)CP.PHAR.691January 1, 2025
axicabtagene ciloleucel (Yescarta®) (PDF)CP.PHAR.362February 1, 2024
Axitinib (Inlyta) (PDF)CP.PHAR.100April 1, 2024
Azacitidine (Vidaza) (PDF)CP.PHAR.387March 1, 2025
Azacitidine (Vidaza) (PDF)CP.PHAR.387Retire by March 1, 2025
Azelaic Acid (Finacea) (PDF)HIM.PA.119January 1, 2025
Aztreonam (Cayston) (PDF)CP.PHAR.209September 1, 2024
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax)CP.PHAR.149January 1, 2025
Baloxavir Marboxil (Xofluza) (PDF)CP.PMN.185January 1, 2025
Bamlanivimab-etesevimab (LY-CoV555-LY-CoV016) (PDF)CP.PHAR.532July 1, 2023
Bardoxolone Methyl (RTA 402) (PDF)CP.PHAR.560December 1, 2023
Bedaquiline (Sirturo) (PDF)CP.PMN.212September 1, 2024
Belatacept (Nulojix®) (PDF)CP.PHAR.201January 1, 2025
Belimumab (Benlysta) (PDF)CP.PHAR.88October 1, 2024
Belinostat (Beleodaq®) (PDF)CP.PHAR.311March 1, 2025
Belinostat (Beleodaq®) (PDF)CP.PHAR.311Retire by March 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF)CP.PMN.237September 1, 2024
Bendamustine (Bendeka®, Treanda®) (PDF)CP.PHAR.307March 1, 2025
Bendamustine (Bendeka®, Treanda®) (PDF)CP.PHAR.307Retire by March 1, 2025
Benralizumab (Fasenra) (PDF)HIM.PA.SP70March 1, 2025
Benralizumab (Fasenra) (PDF)CP.PHAR.373January 1, 2025
Benralizumab (Fasenra) (PDF)CP.PHAR.373Retire by January 1, 2025
Benznidazole (PDF)CP.PMN.90February 1, 2024
Berdazimer (Zelsuvmi) (PDF)CP.PMN.293June 1, 2024
Beremagene Geperpavec (Vyjuvek) (PDF)CP.PHAR.592September 1, 2024
Betaine (Cystadane) (PDF)CP.PHAR.143March 1, 2025
Betaine (Cystadane) (PDF)CP.PHAR.143Retire by March 1, 2025
Betibeglogene autotemcel (PDF)CP.PHAR.545October 1, 2024
Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF)CP.PHAR.93March 1, 2025
Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF)CP.PHAR.93Retire by March 1, 2025
Bexarotene (Targretin) (PDF)CP.PHAR.75July 1, 2024
Bezlotoxumab (Zinplava) (PDF)CP.PHAR.300February 1, 2024
Belantamab mafodotin (Blenrep) (PDF)CP.PHAR.469June 1, 2024
Belumosudil (Rezurock) (PDF)CP.PHAR.552January 1, 2025
Belzutifan (Welireg) (PDF)CP.PHAR.553January 1, 2025
Berotralstat (Orladeyo) (PDF)HIM.PA.169September 1, 2024
Betamethasone Dipropionate Spray (Sernivo) (PDF)CP.PMN.182January 1, 2025
Bimatoprost Implant (Durysta) (PDF)CP.PHAR.486June 1, 2024
Binimetinib (Mektovi) (PDF)CP.PHAR.50July 1, 2024
Biologic and Non-biologic DMARDs (PDF)HIM.PA.SP60January 1, 2025
Biologic and Non-biologic DMARDs (PDF)HIM.PA.SP60Retire by January 1, 2025
Birch Triterpenes (Filsuvez) (PDF)CP.PHAR.669July 1, 2024
Blinatumomab (Blincyto) (PDF)CP.PHAR.312November 1, 2024
Bortezomib (Velcade) (PDF)CP.PHAR.410February 1, 2024
Bosentan (Tracleer®) (PDF)CP.PHAR.191February 1, 2024
Bosutinib (Bosulif) (PDF)CP.PHAR.105August 1, 2024
Brand Name Override and Non-Formulary Medications (PDF)HIM.PA.103January 1, 2025
Brentuximab Vedotin (Adcetris) (PDF)CP.PHAR.303October 1, 2024
Brexanolone (Zulresso) (PDF)CP.PHAR.417June 1, 2024
Brexpiprazole (Rexulti) (PDF)CP.PMN.68September 1, 2024
Brexucabtagene Autoleucel (Tecartus) (PDF)CP.PHAR.472April 1, 2024
Brigatinib (Alunbrig) (PDF)CP.PHAR.342July 1, 2024
Brivaracetam (Briviact) (PDF)CP.PMN.297January 1, 2025
Brolucizumab-dbll (Beovu) (PDF)CP.PHAR.445February 1, 2024
Brimonidine Tartrate (Mirvaso) (PDF)CP.PMN.192June 1, 2024
Brinzolamide/Brimonidine (Simbrinza) (PDF)HIM.PA.15January 1, 2025
Brivaracetam (Briviact) (PDF)CP.PCH.26January 1, 2025
Brivaracetam (Briviact) (PDF)CP.PCH.26Retire by January 1, 2025
Budesonide (Eohilia, Uceris) (PDF)CP.PMN.294June 1, 2024
Budesonide (Tarpeyo) (PDF)CP.PHAR.572September 1, 2024
Buprenorphine (Sublocade, Brixaldi) (PDF)CP.PHAR.289August 1, 2024
Bupropion/Naltrexone (Contr07e) (PDF)CP.PCH.12July 1, 2024
Burosumab-twza (Crysvita) (PDF)CP.PHAR.11October 1, 2024
Buprenorphine/Naloxone (Bunavail, Cassipa, Suboxone, Zubsolv) (PDF)CP.PMN.81August 1, 2024
Buprenorphine (Subutex)CP.PMN.82August 1, 2024
Butorphanol Nasal Spray (PDF)HIM.PA.46June 1, 2024
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF)HIM.PA.170September 1, 2024
cabazitaxel (Jevtana®) (PDF)CP.PHAR.316June 1, 2024
Cabotegravir, Cabotegravir-Rilpivirine (Apretude Cabenuva) (PDF)CP.PHAR.573October 1, 2024
Cabozantinib (Cometriq®, Cabometyx®) (PDF)CP.PHAR.111April 1, 2024
Calcifediol (Rayaldee) (PDF)CP.PMN.76September 1, 2024
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF)CP.PMN.181January 1, 2025
Canakinumab (Ilaris) (PDF)CP.PHAR.246July 1, 2024
Cannabidiol (Epidiolex) (PDF)CP.PMN.164September 1, 2024
Capecitabine (Xeloda) (PDF)CP.PHAR.60November 1, 2024
Capivasertib (Truqap) (PDF)CP.PHAR.663February 1, 2024
Caplacizumab-yhdp (Cablivi) (PDF)CP.PHAR.416June 1, 2024
Capmatinib (Tabrecta) (PDF)CP.PHAR.494September 1, 2024
Carbetocin (PDF)CP.PHAR.546Pending FDA Approval
Carbidopa-Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa) (PDF)CP.PMN.238January 1, 2025
Carbidopa-Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa) (PDF)CP.PMN.238Retire by January 1, 2025
Carfilzomib (Kyprolis®) (PDF)CP.PHAR.309March 1, 2025
Carfilzomib (Kyprolis®) (PDF)CP.PHAR.309Retire by March 1, 2025
Carglumic acid (Carbaglu®) (PDF)CP.PHAR.206February 1, 2024
Cariprazine (Vraylar) (PDF)CP.PMN.91October 1, 2024
Casimersen (Amondys 45) (PDF)CP.PHAR.470March 1, 2024
Casirivimab and imdevimab (REGEN-COV) (PDF)CP.PHAR.520July 1, 2023
Celecoxib (Celebrex) (PDF)CP.PMN.122December 1, 2023
Cemiplimab-rwlc (Libtayo) (PDF)CP.PHAR.397January 1, 2025
Cenegermin-bkbj (Oxervate)(PDF)CP.PMN.186February 1, 2024
Cenobamate (Xcopri) (PDF)CP.PMN.231February 1, 2024
Ceritinib (Zykadia) (PDF)CP.PHAR.349June 1, 2024
Cerliponase alfa (Brineura) (PDF)CP.PHAR.338October 1, 2024
Cetuximab (Erbitux®) (PDF)CP.PHAR.317March 1, 2025
Cetuximab (Erbitux®) (PDF)CP.PHAR.317Retire by March 1, 2025
Chenodiol (Chenodal) (PDF)CP.PMN.239September 1, 2024
Chlorambucil (Leukeran) (PDF)CP.PHAR.554March 1, 2025
Chlorambucil (Leukeran) (PDF)CP.PHAR.554Retire by March 1, 2025
Chloramphenicol Sodium Succinate (PDF)CP.PHAR.388September 1, 2024
Cholic Acid (Cholbam) (PDF)CP.PHAR.390January 1, 2025
Ciclopirox (Penlac) (PDF)CP.PMN.24February 1, 2024
Ciltacabtagene Autoleucel (Carvykti) (PDF)CP.PHAR.533January 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF)CP.PHAR.533Retire by January 1, 2025
Cinacalcet (Sensipar) (PDF)CP.PHAR.61October 1, 2024
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF)CP.PHAR.567April 1, 2024
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF)CP.PMN.248January 1, 2025
Ciprofloxacin/Fluocinolone (Otovel) (PDF)CP.PMN.249January 1, 2025
Cladribine (Mavenclad) (PDF)CP.PHAR.422June 1, 2024
Clascoterone (Winlevi) (PDF)CP.PMN.257April 1, 2024
Clobazam (Onfi) (PDF)CP.PMN.54January 1, 2025
CNS Stimulants (PDF)CP.PMN.92February 1, 2024
Cobimetinib (Cotellic) (PDF)CP.PHAR.380July 1, 2024
Colchicine (Colcrys, Lodoco) (PDF)CP.PMN.123September 1, 2024
Colesevelam (Welchol) (PDF)CP.PMN.250January 1, 2025
Collagenase (Xiaflex) (PDF)CP.PHAR.82September 1, 2024
Colonoscopy Preparation Products (PDF)CP.PCH.43January 1, 2025
Compounded Medications (PDF)CP.PMN.280September 1, 2024
Concizumab (NN7415) (PDF)CP.PHAR.625June 1, 2024
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF)CP.PMN.258February 1, 2024
Continuous Glucose Monitors (PDF)CP.PMN.214January 1, 2025
Copanlisib (Aliqopa®) (PDF)CP.PHAR.357March 1, 2025
Copanlisib (Aliqopa®) (PDF)CP.PHAR.357Retire by March 1, 2025
Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (PDF)CP.PHAR.385November 1, 2024
Corticotropin (H.P. Acthar, Purified Cortrophin Gel) (PDF)HIM.PA.168July 1, 2024
Cosyntropin (Cortrosyn) (PDF)CP.PHAR.203February 1, 2024
Crisaborole (Eucrisa) (PDF)CP.PMN.110June 1, 2024
Crizanlizumab-tmca (Adakveo) (PDF)CP.PHAR.449February 1, 2024
Crizotinib (Xalkori) (PDF)CP.PHAR.90June 1, 2024
Crovalimab (PDF)CP.PHAR.664October 1, 2024
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF)CP.PMN.48January 1, 2025
Cysteamine ophthalmic (Cystaran) (PDF)CP.PMN.130June 1, 2024
Cysteamine oral (Cystagon, Procysbi) (PDF)CP.PHAR.155June 1, 2024
Cytomegalovirus Immune Globulin (Cytogam) (PDF)CP.PHAR.277September 1, 2024
Dabrafenib (Tafinlar) (PDF)CP.PHAR.239July 1, 2024
Dacomitinib (Vizimpro) (PDF)CP.PHAR.399January 1, 2025
Dalfampridine (Ampyra) (PDF)CP.PHAR.248June 1, 2024
Dalteparin (Fragmin) (PDF)CP.PHAR.225February 1, 2024
Danicopan (ALXN2040) (PDF)CP.PHAR.665October 1, 2024
Daprodustat (Jesduvroq) (PDF)CP.PHAR.628August 1, 2024
Daptomycin (Cubicin, Cubicin RF) (PDF)CP.PHAR.351September 1, 2024
Dapsone (Aczone Gel) (PDF)CP.PCH.32March 1, 2025
Dapsone (Aczone Gel) (PDF)CP.PCH.32Retire by March 1, 2025
Daratumumab (Darzalex) (PDF)CP.PHAR.310November 1, 2024
Darbepoetin alfa (Aranesp) (PDF)CP.PHAR.236August 1, 2024
Darolutamide (Nubeqa) (PDF)CP.PHAR.435January 1, 2025
Darolutamide (Nubeqa) (PDF)CP.PHAR.435Retire by January 1, 2025
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF)HIM.PA.SP61September 1, 2024
Dasatinib (Sprycel) (PDF)CP.PHAR.72August 1, 2024
Dasiclucagon (ZP4207) (PDF)CP.PHAR.642December 1, 2023
DaxibotulinumtoxinA-lanm (Daxxify) (PDF)CP.PHAR.651January 1, 2025
Daunorubicin/cytarabine (Vyxeos®) (PDF)CP.PHAR.352January 1, 2025
Decitabine-Cedazuridine (Inqovi) (PDF)CP.PHAR.479August 1, 2024
Deferasirox (Exjade Jadenu) (PDF)CP.PHAR.145September 1, 2024
Deferoxamine (Desferal) (PDF)CP.PHAR.146September 1, 2024
Deflazacort (Emflaza) (PDF)CP.PHAR.331October 1, 2024
Degarelix Acetate (Firmagon) (PDF)CP.PHAR.170January 1, 2025
Delafloxacin (Baxdela) (PDF)CP.PMN.115September 1, 2024
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)CP.PHAR.593November 1, 2024
Denileukin Diftitox-cxdl (Lymphir) (PDF)CP.PHAR.693January 1, 2025
Denosumab (Prolia, Xgeva) (PDF)CP.PHAR.58November 1, 2024
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF)CP.PHAR.214February 1, 2024
Deutetrabenazine (Austedo) (PDF)CP.PCH.42September 1, 2024
Dexrazoxane (Zinecard, Totect) (PDF)CP.PHAR.418July 1, 2024
Dextromethorphan-bupropion (Auvelity) (PDF)CP.PMN.284January 1, 2025
Diazepam Nasal Spray (Valtoco)(PDF)CP.PMN.216January 1, 2025
Dichlorphenamide (Keveyis) (PDF)CP.PMN.261February 1, 2024
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF)CP.PCH.28January 1, 2025
Dimethyl fumarate (Tecfidera), diroximel fumarate, monomethyl fumarate (PDF)CP.PHAR.249June 1, 2024
Enfuvirtide (Fuzeon) (PDF)CP.PHAR.41September 1, 2024
Dipeptidyl Peptidase-4 Inhibitors (PDF)HIM.PA.58October 1, 2024
Dolasetron (Anzemet) (PDF)CP.PMN.141September 1, 2024
Donanemab-azbt (Kinsunla) (PDF)CP.PHAR.594March 1, 2025
Donanemab-azbt (Kinsunla) (PDF)CP.PHAR.594Retire by March 1, 2025
Donislecel (Lantidra) (PDF)CP.PHAR.569December 1, 2023
Dornase alfa (Pulmozyme) (PDF)CP.PHAR.212September 1, 2024
Dostarlimab-gxly (Jemperli) (PDF)CP.PHAR.540November 1, 2024
Doxepin Hydrochloride Cream (Prudoxin, Zonalon) (PDF)HIM.PA.147January 1, 2025
Doxycycline (Doryx, Oracea, Acticlate) (PDF)CP.PMN.79June 1, 2024
Dupilumab (Dupixent) (PDF)CP.PHAR.336July 1, 2024
Durvalumab (Imfinzi) (PDF)CP.PHAR.339November 1, 2024
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF)CP.PMN.128June 1, 2024
Duvelisib (Copiktra) (PDF)CP.PHAR.400March 1, 2025
Duvelisib (Copiktra) (PDF)CP.PHAR.400Retire by March 1, 2025
Ecallantide (Kalbitor) (PDF)CP.PHAR.177September 1, 2024
Eculizumab (Soliris) (PDF)CP.PHAR.97October 1, 2024
Edaravone (Radicava, Radivaca ORS) (PDF)CP.PHAR.343June 1, 2024
Efgartigimod alfa, efgartigimod-hyaluronidase (Vyvgart, Vyvgart Hytrulo) (PDF)CP.PHAR.555
January 1, 2025
Efinaconazole (Jublia) (PDF)CP.PMN.25February 1, 2024
Eflornithine (Iwilfin) (PDF)CP.PHAR.670March 1, 2024
Elacestrant (Orserdu) (PDF)CP.PHAR.623June 1, 2024
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF)CP.PHAR.136March 1, 2025
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF)CP.PHAR.136Retire by March 1, 2025
Elapegademase-lvlr (Revcovi) (PDF)CP.PHAR.419June 1, 2024
Elbasvir/Grazoprevir (Zepatier) (PDF)HIM.PA.SP62September 1, 2024
Elafibranor (Iqirvo) (PDF)CP.PHAR.688September 1, 2024
Eliglustat (Cerdelga) (PDF)CP.PHAR.153June 1, 2024
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF)CP.PHAR.440September 1, 2024
Elosulfase Alfa (Vimizim) (PDF)CP.PHAR.162June 1, 2024
Elotuzumab (Empliciti) (PDF)CP.PHAR.308March 1, 2025
Elotuzumab (Empliciti) (PDF)CP.PHAR.308Retire by March 1, 2025
Elranatamab-bcmm (Elrexfio) (PDF)CP.PHAR.652January 1, 2025
Eltrombopag (Promacta®) (PDF)CP.PHAR.180April 1, 2024
Eluxadoline (Viberzi) (PDF)CP.PMN.170January 1, 2025
Elivaldogene Autotemcel (PDF)CP.PHAR.556January 1, 2025
Emapalumab-lzsg (Gamifant)(PDF)CP.PHAR.402April 1, 2024
Emicizumab-kxwh (Hemlibra) (PDF)CP.PHAR.370June 1, 2024
Emtricitabine-tenofovir alafenamide (Descovy) (PDF)CP.PMN.235August 1, 2024
Enasidenib (Idhifa) (PDF)CP.PHAR.363January 1, 2025
Encorafenib (Braftovi) (PDF)CP.PHAR.127June 1, 2024
Enfuvirtide (Fuzeon) (PDF)CP.PHAR.41July 1, 2021
Enfortumab Vedotin-ejfv (Padcev) (PDF)CP.PHAR.455February 1, 2024
Enoxaparin (Lovenox) (PDF)CP.PHAR.224February 1, 2024
Entecavir (Baraclude) (PDF)HIM.PA.08June 1, 2024
Entrectinib (Rozlytrek) (PDF)CP.PHAR.441March 1, 2025
Entrectinib (Rozlytrek) (PDF)CP.PHAR.441Retire by March 1, 2025
Enzalutamide (Xtandi) (PDF)CP.PHAR.106April 1, 2024
Enzalutamide (Xtandi) (PDF)HIM.PA.164May 1, 2023
Epcoritamab-bysp (Epkinly) (PDF)CP.PHAR.634September 1, 2024
Eplontersen (AKCEA-TTR-LRx) (PDF)CP.PHAR.633September 1, 2024
Epoetin Alfa (Epogen® and Procrit) (PDF)CP.PHAR.237August 1, 2024
Epoprostenol (PDF)CP.PHAR.192February 1, 2024
Eptinezumab-jjmr (Vyepti) (PDF)HIM.PA.SP64March 1, 2025
Eptinezumab-jjmr (Vyepti) (PDF)HIM.PA.SP64Retire by March 1, 2025
Erdafitinib (Balversa) (PDF)CP.PHAR.423September 1, 2024
Erenumab-aaoe (Aimovig) (PDF)HIM.PA.SP65March 1, 2025
Erenumab-aaoe (Aimovig) (PDF)HIM.PA.SP65Retire by March 1, 2025
Eribulin Mesylate (Halaven®) (PDF)CP.PHAR.318January 1, 2025
Erlotinib (Tarceva) (PDF)CP.PHAR.74June 1, 2024
Erwinia Asparaginase (Erwinaze) (PDF)CP.PHAR.301February 1, 2024
Esketamine (Spravato) (PDF)CP.PMN.199October 1, 2024
Estradiol Vaginal Ring (Femring) (PDF)CP.PMN.263September 1, 2024
Etelcalcetide (Parsabiv) (PDF)CP.PHAR.379September 1, 2024
Eteplirsen (Exondys 51) (PDF)CP.PHAR.288April 1, 2024
Etranacogene Dezaparvovec (Hemgenix) (PDF)CP.PHAR.580March 1, 2025
Etranacogene Dezaparvovec (Hemgenix) (PDF)CP.PHAR.580Retire by March 1, 2025
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF)CP.PHAR.63April 1, 2024
Evinacumab-dgnb (Evkeeza) (PDF)CP.PHAR.511March 1, 2022
Evinacumab-dgnb (Evkeeza) (PDF)HIM.PA.166April 1, 2024
Evolocumab (Repatha) (PDF)HIM.PA.156July 1, 2024
Exagamglogene autotemcel (Casgevy) (PDF)CP.PHAR.603July 1, 2024
Factor IX (Human, Recombinant) (PDF)CP.PHAR.218June 1, 2024
Factor IX Complex Human (Bebulin®, Profilnine®) (PDF)CP.PHAR.219June 1, 2024
Factor VIIa, Recombinant (NovoSeven® RT) (PDF)CP.PHAR.220September 1, 2024
Factor VIII (Human Recombinant) (PDF)CP.PHAR.215June 1, 2024
Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF)CP.PHAR.216June 1, 2024
Factor XIII A-Subunit, Recombinant (Tretten®)CP.PHAR.222February 1, 2024
Factor XIII, Human (Corifact®) (PDF)CP.PHAR.221February 1, 2024
Fam-trastuzumab Deruxtecan-nxki (Enhertu) (PDF)CP.PHAR.456August 1, 2024
Famotidine-Ibuprofen (Duexis) (PDF)CP.PMN.120July 1, 2024
Faricimab (Vabysmo) (PDF)CP.PHAR.581October 1, 2024
Febuxostat (Uloric) (PDF)CP.PMN.57April 1, 2024
Fecal microbiota, live-jslm (Rebyota) (PDF)CP.PHAR.613February 1, 2024
Fecal microbiota spores, live-brpk (Vowst) (PDF)CP.PHAR.632September 1, 2024
Fedratinib (Inrebic) (PDF)CP.PHAR.442January 1, 2025
Fenfluramine (Fintepla) (PDF)CP.PMN.246September 1, 2024
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF)CP.PMN.127August 1, 2024
Ferric Carboxymaltose (Injectafer) (PDF)CP.PHAR.234September 1, 2024
Ferric Derisomaltose (Monoferric) (PDF)CP.PHAR.480November 1, 2024
Ferric gluconate (Ferrlecit®) (PDF)CP.PHAR.166July 1, 2023
Ferric Maltol (Accrufer) (PDF)CP.PMN.213January 1, 2025
Ferric Pyrophosphate Citrate (Triferic) (PDF)CP.PHAR.624June 1, 2024
Ferumoxytol (Feraheme®) (PDF)CP.PHAR.165September 1, 2024
Fezolinetant (Veozah) (PDF)CP.PMN.289September 1, 2024
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF)CP.PHAR.643January 1, 2025
Flibanserin (Addyi) (PDF)CP.PHAR.446January 1, 2025
Fibrinogen concentrate (human) (Fibryga, RiaSTAP) (PDF)CP.PHAR.526November 1, 2024
Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix) (PDF)CP.PHAR.297November 1, 2024
Finerenone (Kerendia) (PDF)CP.PMN.266January 1, 2025
Fingolimod (Gilenya) (PDF)CP.PCH.38June 1, 2024
Fluorouracil Cream (Tolak) (PDF)CP.PMN.165January 1, 2025
Fluticasone Propionate (Xhance) (PDF)CP.PMN.95November  1, 2024
Fondaparinux (Arixtra) (PDF)CP.PHAR.226February 1, 2024
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF)HIM.PA.33January 1, 2025
Fosdenopterin (Nulibry) (PDF)CP.PHAR.471June 1, 2024
Fostamatinib (Tavalisse) (PDF)CP.PHAR.24April 1, 2024
Fostemsavir (Rukobia) (PDF)CP.PHAR.516August 1, 2024
Fremanezumb-vfrm (PDF)HIM.PA.SP66March 1, 2025
Fremanezumb-vfrm (PDF)HIM.PA.SP66Retire by March 1, 2025
Fruquintinib (Fruzaqla) (PDF)CP.PHAR.666February 1, 2024
Fulvestrant (Faslodex Injection) (PDF)CP.PHAR.424October 1, 2024
Furosemide (Furoscix) (PDF)CP.PHAR.608November 1, 2024
Futibatinib (Lytgobi) (PDF)CP.PHAR.604February 1, 2024
Gabapentin ER (Gralise, Horizant) (PDF)CP.PMN.240September 1, 2024
Galcanezumab-gnlm (Emgality) (PDF)HIM.PA.SP67March 1, 2025
Galcanezumab-gnlm (Emgality) (PDF)HIM.PA.SP67Retire by March 1, 2025
Galsulfase (Naglazyme) (PDF)CP.PHAR.161June 1, 2024
Ganaxolone (Ztalmy) (PDF)CP.PMN.278July 1, 2024
Garadacimab (CSL312)_PEPP (PDF)CP.PHAR.673June 1, 2024 ( Pending FDA Approval)
Gefitinib (Iressa) (PDF)CP.PHAR.68June 1, 2024
Gemtuzumab ozogamicin (Mylotarg®) (PDF)CP.PHAR.358January 1, 2025
Gepirone (Exxua) (PDF)CP.PMN.292Retire by January 1, 2025
Gilteritinib (Xospata) (PDF)CP.PHAR.412March 1, 2024
Givinostat (ITF2357) (PDF)CP.PHAR.644October 1, 2024
Givosiran (Givlaari) (PDF)CP.PHAR.457April 1, 2024
Glasdegib (Daurismo)(PDF)CP.PHAR.413February 1, 2024
Glatiramer (Copaxone, Glatopa) (PDF)CP.PHAR.252June 1, 2024
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF)CP.PMN.286February 1, 2024
Glecaprevir-Pibrentasvir (PDF)HIM.PA.SP36September 1, 2024
Glofitamab-gxbm (Columvi) (PDF)CP.PHAR.636September 1, 2024
Glucagon-Like Peptide-1 Receptor Agonists (PDF)HIM.PA.53February 1, 2024
Glycerol phenylbutyrate (Ravicti®) (PDF)CP.PHAR.207May 1, 2024
Goserelin acetate (Zoladex®) (PDF)CP.PHAR.171January 1, 2025
Goserelin acetate (Zoladex®) (PDF)CP.PHAR.171Retire by January 1, 2025
Granisetron (Kytril, Sancuso, Sustol) (PDF)CP.PMN.74January 1, 2025
Granisetron (Kytril, Sancuso, Sustol) (PDF)CP.PMN.74Retire by January 1, 2025
Halcinonide (Halog) (PDF)HIM.PA.20January 1, 2025
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF)CP.PMN.180January 1, 2025
Halobetasol Propionate/Tazarotene (Duobrii) (PDF)CP.PMN.208September 1, 2024
Hemin (Panhematin®) (PDF)CP.PHAR.181February 1, 2024
Histrelin acetate (Vantas®, Supprelin LA®) (PDF)CP.PHAR.172July 1, 2024
House dust mite allergen extract (Odactra®) (PDF)CP.PMN.111September 1, 2024
Human Growth Hormone (Somapacitan, Somatropin) (PDF)HIM.PA.161September 1, 2024
Hyaluronate Derivatives (PDF)CP.PHAR.05January 1, 2025
Hydroxyprogesterone Caproate (Makena) (PDF)CP.PHAR.14June 1, 2024
Hydroxyurea (Siklos) (PDF)CP.PMN.193August 1, 2024
ibalizumab-uiyk (Trogarzo) (PDF)CP.PHAR.378August 1, 2024
Ibandronate sodium (PDF)CP.PHAR.189April 1, 2024
Ibrutinib (Imbruvica) (PDF)CP.PHAR.126February 1, 2024
Icatibant (Firazyr®) (PDF)CP.PHAR.178September 1, 2024
Icosapent ethyl (Vascepa) (PDF)CP.PMN.187February 1, 2024
Idecabtagene vicleucel (Abecma) (PDF)CP.PHAR.481January 1, 2025
Idecabtagene vicleucel (Abecma) (PDF)CP.PHAR.481Retire by January 1, 2025
Idelalisib (Zydelig) (PDF)CP.PHAR.133March 1, 2025
Idelalisib (Zydelig) (PDF)CP.PHAR.133Retire by March 1, 2025
Idursulfase (Elaprase) (PDF)CP.PHAR.156June 1, 2024
Iloperidone (Fanapt) (PDF)CP.PMN.32January 1, 2025
Iloperidone (Fanapt) (PDF)CP.PMN.32Retire by January 1, 2025
Iloprost (Ventavis®) (PDF)CP.PHAR.193February 1, 2024
Imatinib (Gleevec) (PDF)CP.PHAR.65June 1, 2024
Imetelstat (Rytelo) (PDF)CP.PHAR.690September 1, 2024
Imiglucerase (Cerezyme) (PDF)CP.PHAR.154June 1, 2024
Immune Globulins (PDF)CP.PHAR.103January 1, 2025
Immune Globulins (PDF)CP.PHAR.103Retire by January 1, 2025
Inavolisib (Itovebi) (PDF)CP.PHAR.702January 1, 2025
IncobotulinumtoxinA (Xeomin) (PDF)CP.PHAR.231October 1, 2024
Inhaled Agents for Asthma and COPD (PDF)HIM.PA.153January 1, 2025
Infertility and Fertility Preservation (PDF)CP.PHAR.131March 1, 2025
Infertility and Fertility Preservation (PDF)CP.PHAR.131Retire by March 1, 2025
Inclisiran (Leqvio) (PDF)CP.PHAR.568April 1, 2024
Inebilizumab (PDF)CP.PHAR.458October 1, 2024
Inotersen (Tegsedi) (PDF)CP.PHAR.405June 1, 2024
inotuzumab ozogamicin (Besponsa®) (PDF)CP.PHAR.359January 1, 2025
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)CP.PHAR.534November 1, 2024
Insulin detemir (Levemir) (PDF)HIM.PA.171January 1, 2025
Insulin glargine (Rezvoglar, Semglee, Toujeo) (PDF)HIM.PA.09January 1, 2025
Interferon Beta-1b (Betaseron, Extavia) (PDF)CP.PHAR.255June 1, 2024
Interferon beta-1b (Betaseron, Extavia) (PDF)CP.PCH.46June 1, 2024
Interferon Gamma- 1b (Actimmune) (PDF)CP.PHAR.52February 1, 2024
Intrathecal Baclofen (Gablofen, Lioresal) (PDF)CP.PHAR.149December 1, 2023
Iobenguane I-131 (Azedra) (PDF)CP.PHAR.459February 1, 2024
Ipilimumab (Yervoy) (PDF)CP.PHAR.319June 1, 2024
Iptacopan (LNP023) (PDF)CP.PHAR.656November 1, 2024
Irinotecan Liposome (Onivyde) (PDF)CP.PHAR.304January 1, 2025
Iron sucrose (Venofer®) (PDF)CP.PHAR.167July 1, 2023
Isatuximab-irfc (Sarclisa) (PDF)CP.PHAR.482June 1, 2023
isavuconazonium (Cresemba®) (PDF)CP.PMN.154February 1, 2024
Isotretinoin (Claravis, Absorica, Absorica LD, Myorisan, Zenatane, Amnesteem) (PDF)CP.PMN.143March 1, 2025
Isotretinoin (Claravis, Absorica, Absorica LD, Myorisan, Zenatane, Amnesteem) (PDF)CP.PMN.143Retire by March 1, 2025
Istradefylline (Nourianz) (PDF)CP.PMN.217February 1, 2024
Itraconazole (Sporanox, Onmel) (PDF)CP.PMN.124June 1, 2024
Ivabradine (Corlanor) (PDF)CP.PMN.70February 1, 2024
Ivacaftor (Kalydeco) (PDF)CP.PHAR.210September 1, 2024
Ivermectin (Stromectol, Sklice)CP.PMN.269October 1, 2024
Ivosidenib (Tibsovo) (PDF)CP.PHAR.137January 1, 2025
Ixazomib (Ninlaro) (PDF)CP.PHAR.302September 1, 2024
Ketamine (Ketalar) (PDF)CP.PMN.296September 1, 2024
Ketorolac nasal spray (Sprix) (PDF)CP.PMN.282March 1, 2025
Ketorolac nasal spray (Sprix) (PDF)CP.PMN.282Retire by March 1, 2025
Lacosamide (Vimpat) (PDF)CP.PMN.155August 1, 2022
L-glutamine (Endari) (PDF)CP.PMN.116March 1, 2025
L-glutamine (Endari) (PDF)CP.PMN.116Retire by March 1, 2025
Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi) (PDF)CP.PMN.251December 1, 2022
Lanadelumab-fylo (Takhzyro) (PDF)HIM.PA.172September 1, 2024
Lanreotide (Somatuline Depot and Unbranded) (PDF)CP.PHAR.391January 1, 2025
Lanreotide (Somatuline Depot and Unbranded) (PDF)CP.PHAR.391Retire by January 1, 2025
lapatinib (Tykerb®) (PDF)CP.PHAR.79March 1, 2025
lapatinib (Tykerb®) (PDF)CP.PHAR.79Retire by March 1, 2025
Laronidase (Aldurazyme) (PDF)CP.PHAR.152June 1, 2024
Larotrectinib (Vitrakvi)(PDF)CP.PHAR.414August 1, 2024
Lasmiditan (Reyvow) (PDF)CP.PMN.218April 1, 2024
Latanoprostene Bunod (Vyzulta) (PDF)CP.PMN.108May 1, 2023
Lazertinib (Lazcluze) (PDF)CP.PHAR.695January 1, 2025
Lecanemab-irmb (Leqembi) (PDF)CP.PHAR.596March 1, 2025
Lecanemab-irmb (Leqembi) (PDF)CP.PHAR.596Retire by March 1, 2025
Ledipasvir-Sofosbuvir (Harvoni) (PDF)HIM.PA.SP3September 1, 2024
Lefamulin (Xenleta) (PDF)CP.PMN.219September 1, 2024
Lenacapavir (Sunlenca) (PDF)CP.PHAR.622August 1, 2024
Lenalidomide (Revlimid) (PDF)CP.PHAR.71July 1, 2024
Lenvatinib (Lenvima) (PDF)CP.PHAR.138March 1, 2025
Lenvatinib (Lenvima) (PDF)CP.PHAR.138Retire by March 1, 2025
Leniolisib (Joenja) (PDF)CP.PHAR.597January 1, 2025
Letermovir (Prevymis) (PDF)CP.PHAR.367Retire by January 1, 2025
Letermovir (Prevymis) (PDF)CP.PHAR.367January 1, 2025
Leucovorin Injection (PDF)CP.PHAR.393December 1, 2023
Levodopa Inhalation Powder (Inbrija) (PDF)CP.PMN.267January 1, 2025
Levoleucovorin (Fusilev, Khapzory) (PDF)CP.PHAR.151January 1, 2025
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF)CP.PHAR.173January 1, 2025
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)CP.PCH.53January 1, 2025
Levoketoconazole (Recorlev) (PDF)CP.PMN.275June 1, 2024
Levomilnacipran (Fetzima) (PDF)HIM.PA.125October 1, 2024
Lifileucel (Amtagvi) (PDF)CP.PHAR.598January 1, 2025
Lifitegrast (Xiidra®) (PDF)CP.PMN.73January 1, 2025
Linaclotide (Linzess) (PDF)CP.PMN.71December 1, 2023
Linezolid (Zyvox) (PDF)CP.PMN.27October 1, 2024
Lisocabtagene Maraleucel (Breyanzi) (PDF)CP.PHAR.483July 1, 2024
Lofexidine (Lucemyra) (PDF)CP.PMN.152September 1, 2024
Lomustine (Gleostine) (PDF)CP.PHAR.507January 1, 2025
Lonafarnib (Zokinvy) (PDF)CP.PHAR.499February 1, 2024
Loncastuximab tesirine-lpyl (Zynlonta) (PDF)CP.PHAR.539September 1, 2024
Lorlatinib (Lorbrena)(PDF)CP.PHAR.406June 1, 2024
Loteprednol etabonate (Eysuvis) (PDF)CP.PMN.260February 1, 2024
Lotilaner (Xdemvy) (PDF)CP.PMN.291January 1, 2025
Lovotibeglogene Autotemcel (Lovo-Cel) (PDF)CP.PHAR.627August 1, 2024
Lubiprostone (Amitiza) (PDF)CP.PMN.142January 1, 2025
Luliconazole Cream (Luzu) (PDF)CP.PMN.166February 1, 2024
Lumacaftor-Ivacaftor (Orkambi) (PDF)CP.PHAR.213September 1, 2024
Lumasiran (Oxlumo) (PDF)CP.PHAR.473August 1, 2024
Lumateperone (Caplyta) (PDF)CP.PMN.232September 1, 2024
Lurbinectedin (Zepzelca) (PDF)CP.PHAR.500September 1, 2024
Lurasidone (Latuda) (PDF)CP.PMN.50March 1, 2023
Luspatercept-aamt (Reblozyl) (PDF)CP.PHAR.450December 1, 2024
Luspatercept-aamt (Reblozyl) (PDF)CP.PHAR.450Retire by December 1, 2024
Lusutrombopag (Mulpleta)(PDF)CP.PHAR.407April 1, 2024
Lutetium Lu 177 Dotatate (Lutathera) (PDF)CP.PHAR.384September 1, 2024
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) 09.09.22.docxCP.PHAR.582June 1, 2024
Macitentan (Opsumit) (PDF)CP.PHAR.194February 1, 2024
Macitentan (Opsumit®) (PDF)CP.PCH.31March 1, 2022
Mannitol (Bronchitol) (PDF)CP.PHAR.518September 1, 2024
Maralixibat (Livmarli) (PDF)CP.PHAR.543Retire by January 1, 2025
Maralixibat (Livmarli) (PDF)CP.PHAR.543January 1, 2025
Margetuximab-cmkb (Margenza) (PDF)CP.PHAR.522March 1, 2024
Maribavir (Livtencity) (PDF)CP.PMN.271April 1, 2024
Marstacimab (PF-06741086)_PEPP (PDF)CP.PHAR.674June 1, 2024 ( Pending FDA Approval)
Mavacamten (MYK-461) (PDF)CP.PMN.272September 1, 2024
Mavorixafor (Xolremdi)CP.PHAR.679July 1, 2024
Mecamylamine (Vecamyl) (PDF)CP.PMN.136June 1, 2024
Mecasermin (Increlex) (PDF)CP.PHAR.150October 1, 2024
Megestrol Acetate 125 mg/mL Oral Suspension (Megace ES) (PDF)CP.PMN.179January 1, 2025
Melphalan (Hepzato) (PDF)CP.PHAR.653January 1, 2025
Melphalan flufenamide (Pepaxto) (PDF)CP.PHAR.535May 1, 2024
Memantine (Namenda XR, Namzaric) (PDF)CP.PCH.30September 1, 2024
Mepolizumab (Nucala) (PDF)CP.PHAR.200January 1, 2025
Mepolizumab (Nucala) (PDF)CP.PHAR.200Retire by January 1, 2025
Mercaptopurine (Purixan) (PDF)CP.PHAR.447August 1, 2024
Metformin ER (Glumetza, Fortamet) (PDF)CP.PMN.72February 1, 2024
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF)CP.PHAR.134January 1, 2025
Methoxsalen (Uvadex) (PDF)HIM.PA.17January 1, 2025
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF)CP.PHAR.238August 1, 2024
Methylnaltrexone Bromide (Relistor) (PDF)CP.PMN.169January 1, 2025
Metoclopramide (Gimoti) (PDF)CP.PMN.252March 1, 2025
Metoclopramide (Gimoti) (PDF)CP.PMN.252Retire by March 1, 2025
Metreleptin (Myalept) (PDF)CP.PHAR.425September 1, 2024
Midazolam (Nayzilam) (PDF)CP.PMN.211September 1, 2024
Midostaurin (Rydapt) (PDF)CP.PHAR.344July 1, 2024
Mifepristone (Korlym) (PDF)CP.PHAR.101February 1, 2024
Migalastat (Galafold) (PDF)CP.PHAR.394January 1, 2025
Miglustat (Zavesca) (PDF)CP.PHAR.164June 1, 2024
Milnacipran (Savella) (PDF)CP.PMN.125October 1, 2024
Minocycline micronized foam (Amzeeq) (PDF)CP.PMN.242December 1, 2022
Mirvetuximab soravtansine-gynx (Elahere) (PDF)CP.PHAR.617July 1, 2024
Mitapivat (Pyrukynd) (PDF)CP.PHAR.558January 1, 2025
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF)CP.PHAR.495September 1, 2024
Mitoxantrone (Novantrone) (PDF)CP.PHAR.258July 1, 2024
Mixed pollens allergen extract (Oralair) (PDF)CP.PMN.85September 1, 2024
Mobocertinib (Exkivity) (PDF)CP.PHAR.559January 1, 2025
Modafinil (Provigil) (PDF)CP.PMN.39June 1, 2023
Mogamulizumab-kpkc (Poteligeo) (PDF)CP.PHAR.139March 1, 2025
Mogamulizumab-kpkc (Poteligeo) (PDF)CP.PHAR.139Retire by March 1, 2025
Momelotinib (Ojjaara) (PDF)CP.PHAR.654January 1, 2025
Mometasone (Nasonex) (PDF)HIM.PA.93October 1, 2024
Montelukast oral granules (Singulair) (PDF)HIM.PA.129December 1, 2023
Mosunetuzumab-axgb (Lunsumio) (PDF)CP.PHAR.618February 1, 2024
Motixafortide (Aphexda) (PDF)CP.PHAR.655January 1, 2025
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF)CP.PHAR.398January 1, 2025
Nabumatone Double-Strength (Relafen DS) (PDF)CP.PMN.287June 1, 2024
Nadofaragene Firadenovec (Instiladrin)(PDF)CP.PHAR.461March 1, 2025
Nadofaragene Firadenovec (Instiladrin)(PDF)CP.PHAR.461Retire by March 1, 2025
Nafarelin acetate (Synarel®) (PDF)CP.PHAR.174July 1, 2024
Naldemedine (Symproic) (PDF)CP.PMN.112January 1, 2025
Nalmefene (Opvee) (PDF)CP.PHAR.638November 1, 2024
Naloxegol (Movantik) (PDF)HIM.PA.167January 1, 2025
Naproxen oral suspension (Naprosyn) (PDF)HIM.PA.130January 1, 2025
Narsoplimab (OMS721) (PDF)CP.PHAR.527June 1, 2024
Natalizumab (Tysabri) (PDF)CP.PHAR.259September 1, 2024
Naxitamab-gqgk (Danyelza) CP.PHAR.523February 1, 2024
Necitumumab (Portrazza®) (PDF)CP.PHAR.320January 1, 2025
Nedosiran (DCR-PHXC) (PDF)CP.PHAR.619August 1, 2024
Nemolizumab-ito (Nemluvio) (PDF)CP.PHAR.703January 1, 2025
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF)CP.PMN.167January 1, 2025
Neratinib (Nerlynx) (PDF)CP.PHAR.365January 1, 2025
Netarsudil (Rhopressa), Netarsudil-Latanoprost (Rocklatan) (PDF)CP.PMN.118May 1, 2023
Netupitant and Palonosetron (Akynzeo) (PDF)CP.PMN.158September 1, 2024
Nifurtimox (Lampit) ^ (PDF)CP.PMN.256March 1, 2025
Nifurtimox (Lampit) ^ (PDF)CP.PMN.256Retire by March 1, 2025
nilotinib (Tasigna) (PDF)CP.PHAR.76July 1, 2024
Nintedanib (Ofev) (PDF)CP.PHAR.285September 1, 2024
Nitisinone (Nityr, Orfadin) (PDF)CP.PHAR.132January 1, 2025
Niraparib (Zejula) (PDF)CP.PHAR.408February 1, 2024
Niraparib and Abiraterone (Akeega) (PDF)CP.PHAR.645March 1, 2025
Niraparib and Abiraterone (Akeega) (PDF)CP.PHAR.645Retire by March 1, 2025
Nirmatrelvir-Ritonavir (Paxlovid) (PDF)CP.PMN.288September 1, 2024
Nirogacestat (Ogsiveo) (PDF)CP.PHAR.671July 1, 2024
Nirsevimab (Beyfortus) (PDF)CP.PHAR.614September 1, 2024
Nitazoxanide (Alinia) (PDF)HIM.PA.152March 1, 2025
Nitazoxanide (Alinia) (PDF)HIM.PA.152Retire by March 1, 2025
Nivolumab (Opdivo) (PDF)CP.PHAR.121March 1, 2025
Nivolumab (Opdivo) (PDF)CP.PHAR.121Retire by March 1, 2025
Nivolumab and Relatlimab (Opdualag) (PDF)CP.PHAR.588September 1, 2023
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF)CP.PHAR.684September 1, 2024
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF)CP.PMN.04October  1, 2024
Non-Formulary and Formulary Contraceptives (PDF)HIM.PA.100June 1, 2024
Non-Formulary Test Strips (PDF)HIM.PA.34February 1, 2024
Nusinersen (Spinraza®) (PDF)CP.PHAR.327February 1, 2024
Obecabtagene autoleucel (AUTO1)_PEPP (PDF)CP.PHAR.675June 1, 2024 Pending FDA Approval
Obeticholic acid (Ocaliva) (PDF)CP.PHAR.287September 1, 2024
Obinutuzumab (Gazyva®) (PDF)CP.PHAR.305January 1, 2025
Ocrelizumab (Ocrevus) (PDF)CP.PHAR.335June 1, 2024
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)CP.PHAR.40September 1, 2024
Odevixibat (Bylvay) (PDF)CP.PHAR.528June 1, 2024
Ofatumumab (Arzerra®) (PDF)CP.PHAR.306June 1, 2024
Off-label Policy (PDF)HIM.PA.154January 1, 2025
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF)CP.PHAR.292September 1, 2024
Olanzapine-samidorphan (Lybalvi) (PDF)CP.PMN.265September 1, 2024
Olaparib (Lynparza) (PDF)CP.PHAR.360February 1, 2024
Olaratumab (Lartruvo®) (PDF)CP.PHAR.326December 1, 2023
Olipudase alfa-rpcp (Xenpozyme) 09.08.22.docxCP.PHAR.586September 1, 2024
Olutasidenib (Rezlidhia) (PDF)CP.PHAR.615February 1, 2024
Omacetaxine (Synribo) (PDF)CP.PHAR.108June 1, 2024
Omadacycline (Nuzyra)(PDF)CP.PMN.188September 1, 2024
Omalizumab (Xolair) (PDF)CP.PCH.49August 1, 2024
Omalizumab (Xolair®) (PDF)CP.PHAR.01August 1, 2024
Omaveloxolone (RTA-408) (PDF)CP.PHAR.590June 1, 2024
Omburtamab (Omblastys) (PDF)CP.PHAR.585December 1, 2023
OnabotulinumtoxinA (Botox) (PDF)CP.PHAR.232January 1, 2025
OnabotulinumtoxinA (Botox) (PDF)CP.PHAR.232Retire by January 1, 2025
Onasemnogene abeparvovec (Zolgensma) (PDF)CP.PHAR.421September 1, 2024
Ondansetron (Zuplenz) (PDF)CP.PMN.45August 1, 2024
Ophthalmic Corticosteroids (PDF)HIM.PA.03January 1, 2025
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF)CP.PHAR.536June 1, 2024
Opicapone (Ongentys) (PDF)CP.PMN.245September 1, 2024
Opioid Analgesics (PDF)HIM.PA.139June 1, 2024
Osilodrostat (Isturisa) (PDF)CP.PHAR.487September 1, 2024
Osimertinib (Tagrisso) (PDF)CP.PHAR.294June 1, 2024
Ospemifene (Osphena) (PDF)CP.PMN.168January 1, 2025
Overactive Bladder Agents (PDF)CP.PMN.198December 1, 2023
Oxymetazoline (Rhofade) (PDF)CP.PMN.86June 1, 2024
Ozanimod (Zeposia) (PDF)CP.PHAR.462September 1, 2024
Ozenoxacin (Xepi) (PDF)CP.PMN.119June 1, 2024
Paclitaxel, protein-bound (Abraxane) (PDF)CP.PHAR.176November 1, 2024
Pacritinib (Vonjo) (PDF)CP.PHAR.583June 1, 2024
Palbociclib (Ibrance) (PDF)HIM.PA.173March 1, 2025
Palbociclib (Ibrance) (PDF)HIM.PA.173Retire by March 1, 2025
Paliperidone inj (Invega Sustenna, Invega Trinza, Invega Hafyera) (PDF)CP.PHAR.291November 1, 2024
Palivizumab (Synagis) (PDF)CP.PHAR.16June 1, 2024
Palopegteriparatide (Yorvipath) (PDF)CP.PHAR.696January 1, 2025
Palovarotene (PDF)CP.PHAR.548September 1, 2024
Pancrelipase (Creon, Pancreaze, Pertyze, Viokace, Zenpep) (PDF)CP.PCH.44January 1, 2025
Panitumumab (Vectibix®) (PDF)CP.PHAR.321March 1, 2025
Panitumumab (Vectibix®) (PDF)CP.PHAR.321Retire by March 1, 2025
Panobinostat (Farydak) (PDF)CP.PHAR.382September 1, 2024
Parathyroid Hormone (Natpara) (PDF)CP.PHAR.282February 1, 2024
Paricalcitol Injection (Zemplar) (PDF)CP.PHAR.270September 1, 2024
Pasireotide (Signifor LAR®) (PDF)CP.PHAR.332January 1, 2025
Patiromer (Veltassa) (PDF)CP.PMN.205September 1, 2024
Patisiran (Onpattro) (PDF)CP.PHAR.395July 1, 2024
Pazopanib (Votrient) (PDF)CP.PHAR.81September 1, 2024
Peanut allergen powder (Palforzia) (PDF)CP.PMN.220September 1, 2024
Pegaptanib (Macugen) (PDF)CP.PHAR.185May 1, 2023
Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (PDF)CP.PHAR.353March 1, 2025
Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (PDF)CP.PHAR.353Retire by March 1, 2025
Pegcetacoplan (Empaveli0 (PDF)CP.PHAR.524October 1, 2024
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF)CP.PHAR.296September 1, 2024
Peginterferon Alfa-2a (Pegasys) (PDF)CP.PHAR.89September 1, 2024
Peginterferon beta-1a (Plegridy) (PDF)CP.PHAR.271June 1, 2024
Pegloticase (Krystexxa) (PDF)CP.PHAR.115February 1, 2024
Pegunigalsidase Alfa (PRX-102) (PDF)CP.PHAR.512September 1, 2024
Pegvaliase-pqpz (Palynziq) (PDF)CP.PHAR.140March 1, 2025
Pegvaliase-pqpz (Palynziq) (PDF)CP.PHAR.140Retire by March 1, 2025
Pegvisomant (Somavert) (PDF)CP.PHAR.389January 1, 2025
Pembrolizumab (Keytruda®) (PDF)CP.PHAR.322January 1, 2025
Pembrolizumab (Keytruda®) (PDF)CP.PHAR.322Retire by January 1, 2025
Pemetrexed (Alimta, Pemfexy) (PDF)CP.PHAR.368March 1, 2024
Pemigatinib (Pemazyre) (PDF)CP.PHAR.496September 1, 2024
Penicillamine (Cuprimine) (PDF)CP.PCH.09January 1, 2025
Pentosan polysulfate sodium (Elmiron) (PDF)CP.PMN.276June 1, 2023
Perampanel (Fycompa) (PDF)CP.PMN.156September 1, 2024
Perfluorohexyloctane (Miebo) (PDF)CP.PMN.290September 1, 2024
Pertuzumab (Perjeta) (PDF)CP.PHAR.227June 1, 2024
Pertuzumab-trastuzumab-hyaluronidase-zzxf (Phesgo) (PDF)CP.PHAR.501September 1, 2024
Pexidartinib (Turalio)(PDF)CP.PHAR.436March 1, 2025
Pexidartinib (Turalio)(PDF)CP.PHAR.436Retire by March 1, 2025
Phendimetrazine (PDF)CP.PCH.47July 1, 2024
Phentermine (Adipex-P, Lomaira) (PDF)CP.PCH.13July 1, 2024
Phentermine-topiramate (Qsymia) (PDF)CP.CPA.336September 1, 2022
Pilocarpine (Vuity) (PDF)CP.PMN.270January 1, 2025
Pimavanserin (Nuplazid) (PDF)CP.PMN.140September 1, 2024
Pirfenidone (Esbriet) (PDF)CP.PHAR.286September 1, 2024
Pirtobrutinib (Jaypirca) (PDF)CP.PHAR.620July 1, 2024
Pitolisant (Wakix) (PDF)CP.PMN.221September 1, 2024
Plasminogen, Human-tvmh (Ryplazim) (PDF)CP.PHAR.513January 1, 2025
Plecanatide (Trulance) (PDF)CP.PMN.87January 1, 2025
Plerixafor (Mozobil) (PDF)CP.PHAR.323October 1, 2024
Polatuzumab Vedotin-piiq (Polivy) (PDF)CP.PHAR.433September 1, 2024
Pomalidomide (Pomalyst) (PDF)CP.PHAR.116July 1, 2024
Ponatinib (Iclusig) (PDF)CP.PHAR.112August 1, 2024
Ponesimod (Ponvory) (PDF)CP.PHAR.537June 1, 2024
Potassium (Klor-Con) (PDF)HIM.PA.143February 1, 2024
Pozelimab (REGN3918) (PDF)CP.PHAR.626May 1, 2024
Prademagene Zamikeracel (EB-101) (PDF)CP.PHAR.609Pending FDA Approval
Pralatrexate (Folotyn®) (PDF)CP.PHAR.313March 1, 2025
Pralatrexate (Folotyn®) (PDF)CP.PHAR.313Retire by March 1, 2025
Pralsetinib (Gavreto) (PDF)CP.PHAR.514June 1, 2023
Pramlintide (Symlin) (PDF)CP.PMN.129May 1, 2024
Prasterone (Intrarosa) (PDF)CP.PMN.99February 1, 2024
Pregabalin (Lyrica) (PDF)CP.PMN.33July 1, 2024
Pretomanid (PDF)CP.PMN.222February 1, 2024
Progesterone (Crinone, Endometrin, Milprosa) (PDF)CP.PMN.243September 1, 2024
Propranolol (Hemangeol) (PDF)CP.PCH.51June 1, 2024
protein c concentrate, human (Ceprotin®) (PDF)CP.PHAR.330February 1, 2024
propranolol HCL solution (Hemangeol) (PDF)CP.PMN.58January 1, 2024
Prucalopride (Motegrity) (PDF)HIM.PA.159January 1, 2025
Pyrimethamine (Daraprim®) (PDF)CP.PMN.44September 1, 2024
Quantity Limit Override and Dose Optimization (PDF)CP.PMN.59January 1, 2025
Quetiapine ER (Seroquel XR) (PDF)CP.PMN.64October 1, 2024
Quizartinib (Vanflyta) (PDF)CP.PHAR.646January 1, 2025
Ramucirumab (Cyramza) (PDF)CP.PHAR.119February 1, 2024
Ranibizumab (Lucentis) (PDF)CP.PHAR.186Retire by January 1, 2025
Ranibizumab (Lucentis) (PDF)CP.PHAR.186January 1, 2025
Rasagiline (Azilect®) (PDF)HIM.PA.89September 1, 2024
Ravulizumab-cwvz (Ultomiris) (PDF)CP.PHAR.415October 1, 2024
Regorafenib (Stivarga) (PDF)CP.PHAR.107June 1, 2024
Relugolix (Orgovyx) (PDF)CP.PHAR.529June 1, 2024
Remestemcel-L (Ryoncil) (PDF)CP.PHAR.474June 1, 2024
Remetirom (Rezdiffra) (PDF)CP.PHAR.647January 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel) (PDF)CP.PHAR.168May 1, 2023
Repotrectinib (Augtyro) (PDF)CP.PHAR.667September 1, 2024
Respiratory Syncytial Virus Vaccine (Abrysvo) (PDF)CP.PHAR.658January 1, 2025
Respiratory Syncytial Virus Vaccine (Abrysvo) (PDF)CP.PHAR.658Retire by January 1, 2025
Reslizumab (Cinqair) (PDF)CP.PHAR.223February 1, 2024
Retifanlimab-dlwr (Zynyz) (PDF)CP.PHAR.629July 1, 2024
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF)CP.PHAR.141January 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF)CP.PHAR.334March 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF)CP.PHAR.334Retire by March 1, 2025
Rifabutin (Mycobutin) (PDF)CP.PMN.223April 1, 2024
Rifamycin (Aemcolo) (PDF)CP.PMN.196July 1, 2024
Rifaximin (Xifaxan®) (PDF)CP.PMN.47January 1, 2025
Rilonacept (Arcalyst) (PDF)CP.PHAR.266July 1, 2024
Ripretinib (Qinlock) (PDF)CP.PHAR.502September 1, 2024
RimabotulinumtoxinB (Myobloc) (PDF)CP.PHAR.233June 1, 2024
Rimegepant (Nurtec ODT) (PDF)CP.PHAR.490March 1, 2025
Rimegepant (Nurtec ODT) (PDF)CP.PHAR.490Retire by March 1, 2025
Riociguat (Adempas®) (PDF)CP.PHAR.195February 1, 2024
Risdiplam (Evrysdi) (PDF)CP.PHAR.477February 1, 2024
Risedronate (Actonel, Atelvia) (PDF)CP.PMN.100April 1, 2024
Risperidone Long-Acting Injection (Risperdal Consta) (PDF)CP.PHAR.293October 1, 2024
Roflumilast (Daliresp, Zoryve) (PDF)CP.PMN.46September 1, 2024
Rolapitant (Varubi) (PDF)CP.PMN.102September 1, 2024
Romidepsin (Istodax®) (PDF)CP.PHAR.314January 1, 2025
Romiplostim (Nplate®) (PDF)CP.PHAR.179April 1, 2024
Romosozumab-aqqg (Evenity) (PDF)CP.PHAR.428April 1, 2024
Ropeginterferon alfa-2b-njft (Besremi) (PDF)CP.PHAR.570July 1, 2024
Rozanolixizumab-noli (Rystiggo) (PDF)CP.PHAR.648March 1, 2025
Rozanolixizumab-noli (Rystiggo) (PDF)CP.PHAR.648Retire by March 1, 2025
RP-L201 (PDF)CP.PHAR.599December 1, 2023
Rucaparib (Rubraca®) (PDF)CP.PHAR.350February 1, 2024
Rufinamide (Banzel) (PDF)CP.PMN.157September 1, 2024
Ruxolitinib (Jakafi) (PDF)CP.PHAR.98November 1, 2024
Sacituzumab Govitecan-hziy (Trodelvy) (PDF)CP.PHAR.475June 1, 2024
Sacubitril/Valsartan (Entresto) (PDF)CP.PCH.52September 1, 2024
Safinamide (Xadago) (PDF)CP.PMN.113February 1, 2024
Sapropterin (Kuvan) (PDF)CP.PHAR.43July 1, 2024
Sarecycline (Seysara) (PDF)CP.PMN.189February 1, 2024
Sargramostim (Leukine) (PDF)CP.PHAR.295October 1, 2024
Satralizumab-mwge (Enspryng) (PDF)CP.PHAR.463September 1, 2024
Sebelipase Alfa (Kanuma) (PDF)CP.PHAR.159June 1, 2024
Secnidazole (Solosec) (PDF)CP.PMN.103February 1, 2024
Seladelpar (Livdelzi) (PDF)CP.PHAR.698January 1, 2025
Selexipag (Uptravi®) (PDF)CP.PHAR.196April 1, 2024
Selinexor (Xpovio) (PDF)CP.PHAR.431September 1, 2024
Selpercatinib (Retevmo) (PDF)CP.PHAR.478January 1, 2025
Selpercatinib (Retevmo) (PDF)CP.PHAR.478Retire by January 1, 2025
Selumetinib (Koselugo) (PDF)CP.PHAR.464April 1, 2024
Semaglutide (Wegovy) (PDF)CP.PMN.295September 1, 2024
Setmelanotide (Imcivree) (PDF)CP.PHAR.491February 1, 2024
Short ragweed pollen allergen extract (Ragwitek) (PDF)CP.PMN.83September 1, 2024
Sildenafil (Revatio®) (PDF)CP.PHAR.197February 1, 2024
Sildenafil (Viagra) (PDF)CP.PCH.07June 1, 2024
Siponimod (Mayzent) (PDF)CP.PHAR.427Jue 1, 2024
Sipuleucel-T (Provenge) (PDF)CP.PHAR.120June 1, 2024
Sirolimus Protein-Bound Particles (Fyarro), topical gel (Hyftor) (PDF)CP.PHAR.574February 1, 2024
Siltuximab (Sylvant) (PDF)CP.PHAR.329February 1, 2024
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF)CP.PMN.42January 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF)CP.PMN.42Retire by January 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)HIM.PA.91September 1, 2024
Sodium Phenylbutyrate (Buphenyl) (PDF)CP.PHAR.208February 1, 2024
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) 10.06.22.docxCP.PHAR.584August 1, 2024
Sodium thiosulfate (Pedmark) (PDF)CP.PHAR.610May 1, 2024
Sodium Zirconium Cyclosilicate (Lokelma) (PDF)CP.PMN.163September 1, 2024
Sofosbuvir-Velpatasvir (Epclusa) (PDF)HIM.PA.SP1January 1, 2025
Sofosbuvir-Velpatasvir (Epclusa) (PDF)HIM.PA.SP1Retire by January 1, 2025
Sofosbuvir (Sovaldi) (PDF)HIM.PA.SP2September 1, 2024
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF)HIM.PA.SP63September 1, 2024
Solriamfetol (Sunosi) (PDF)CP.PMN.209June 1, 2024
Sonidegib (Odomzo) (PDF)CP.PHAR.272June 1, 204
Sorafenib (Nexavar) (PDF)CP.PHAR.69July 1, 2024
Sotatercept (ACE-011) (PDF)CP.PHAR.657September 1, 2024
Sotorasib (Lumakras) (PDF)CP.PHAR.549September 1, 2024
Sotrovimab (VIR-7831) (PDF)CP.PHAR.541Pending FDA Approval
Sparsentan (Filspari) (PDF)CP.PHAR.631January 1, 2025
Sparsentan (Filspari) (PDF)CP.PHAR.631Retire by January 1, 2025
Spesolimab-sbzo (Spevigo) (PDF)CP.PHAR.606August 1, 2024
Spinosad (Natroba) (PDF)HIM.PA.134September 1, 2024
Step Therapy Criteria (PDF)HIM.PA.109October 1, 2024
Stiripentol (Diacomit) (PDF)CP.PMN.184January 1, 2025
sunitinib (Sutent) (PDF)CP.PHAR.73June 1, 2024
Sutimlimab-jome (Enjaymo) (PDF)CP.PHAR.503June 1, 2024
Suvorexant (Belsomra®) (PDF)CP.PMN.109January 1, 2025
Tadalafil (Adcirca®) (PDF)CP.PHAR.198February 1, 2024
Tadalafil BHP - ED (Cialis) (PDF)CP.PMN.132September 1, 2024
Tafamidis (Vyndaqel, Vyndamax) (PDF)CP.PHAR.432September 1, 2024
Tafasitamab-cxix (Monjuvi) (PDF)CP.PHAR.508March 1, 2025
Tafasitamab-cxix (Monjuvi) (PDF)CP.PHAR.508Retire by March 1, 2025
Talquetamab-tgvs (Talvey) (PDF)CP.PHAR.649March 1, 2025
Talquetamab-tgvs (Talvey) (PDF)CP.PHAR.649Retire by March 1, 2025
Talazoparib (Talzenna)(PDF)CP.PHAR.409June 1, 2024
Taliglucerase Alfa (Elelyso) (PDF)CP.PHAR.157June 1, 2024
Talimogene laherparepvec (Imlygic) (PDF)CP.PHAR.542September 1, 2024
Tapinarof (Vtama) (PDF)CP.PMN.283March 1, 2025
Tapinarof (Vtama) (PDF)CP.PMN.283Retire by March 1, 2025
Tarlatamab-dlle (Imdelltra) (PDF)CP.PHAR.685September 1, 2024
Tasimelteon (Hetlioz) (PDF)CP.PMN.104October 1, 2024
Tavaborole (Kerydin®) (PDF)CP.PMN.105February 1, 2024
Tazarotene (Arazlo, Fabior, Tazorac) (PDF)CP.PMN.244March 1, 2025
Tazarotene (Arazlo, Fabior, Tazorac) (PDF)CP.PMN.244Retire by March 1, 2025
Tazemetostat (PDF)CP.PHAR.452February 1, 2024
Tebentafusp-tebn (Kimmtrak) (PDF)CP.PHAR.575June 1, 2024
Teclistamab-cqyv (Tecvayli) (PDF)CP.PHAR.611February 1, 2024
Tedizolid (Sivextro) (PDF)CP.PMN.62September 1, 2024
Teduglutide (Gattex) (PDF)CP.PHAR.114April 1, 2024
Tegaserod (Zelnorm) (PDF)HIM.PA.160Retire by January 1, 2025
Telotristat ethyl (Xermelo) (PDF)CP.PHAR.337June 1, 2024
Temozolomide (Temodar) (PDF)CP.PHAR.77July 1, 2024
Temsirolimus (Torisel®) (PDF)CP.PHAR.324January 1, 2025
Tenapanor (Ibsrela) (PDF)CP.PMN.224March 1, 2024
Tenapanor (Ibsrela, Xphozah) (PDF)HIM.PA.174January 1, 2025
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF)CP.PMN.268January 1, 2025
Teplizumab (PDF)CP.PHAR.492February 1, 2024 (Previously Pending FDA Approval)
Tepotinib (Tepmetko) (PDF)CP.PHAR.530July 1, 2024
Teprotumumab (Tepezza) (PDF)CP.PHAR.465February 1, 2024
Teriflunomide (Aubagio) (PDF)CP.PCH.40June 1, 2024
Teriparatide (Forteo®) (PDF)CP.PHAR.188April 1, 2024
Tesamorelin (Egrifta) (PDF)CP.PHAR.109October 1, 2024
Testosterone (Androderm) (PDF)HIM.PA.87January 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF)CP.PHAR.354January 1, 2025
Tetrabenazine (Xenazine) (PDF)CP.PHAR.92June 1, 2024
Tezacaftor-Ivacaftor (Symdeko) (PDF)CP.PHAR.377September 1, 2024
Tezepelumab (Tezspire) (PDF)CP.PHAR.576February 1, 2024
Thalidomide (Thalomid) (PDF)CP.PHAR.78July 1, 2024
Thioguanine (Tabloid) (PDF)CP.PHAR.437March 1, 2025
Thioguanine (Tabloid) (PDF)CP.PHAR.437Retire by March 1, 2025
Thyrotropin Alfa (Thyrogen) (PDF)CP.PHAR.95September 1, 2024
Timothy grass pollen allergen extract (Grastek®) (PDF)CP.PMN.84September 1, 2024
Tiopronin Delayed-Release (Thiola EC) (PDF)CP.PCH.50June 1, 2024
Tisagenlecleucel (Kymriah) (PDF)CP.PHAR.361April 1, 2024
Tislelizumab-jsgr (Tevimbra) (PDF)CP.PHAR.687September 1, 2024
Tisotumab Vedotin-tftv (Tivdak)CP.PHAR.561March 1, 2025
Tisotumab Vedotin-tftv (Tivdak)CP.PHAR.561Retire by March 1, 2025
Tivozanib (Fotivda) (PDF)CP.PHAR.538July 1, 2024
Tixagevimab-Cilgavimab (Evusheld) (PDF)CP.PHAR.571July 1, 2023
Tobramycin (PDF)CP.PHAR.211September 1, 2024
Tocilizumab
(Actemra), Tocilizumab-bavi (Tofidence), Tocilizumab-aazg (Tyenne) (PDF)
CP.PHAR.263Retire by January 1, 2025
Tocilizumab
(Actemra), Tocilizumab-bavi (Tofidence), Tocilizumab-aazg (Tyenne)(PDF)
CP.PHAR.263January 1, 2025
Tofersen (Qalsody) (PDF)CP.PHAR.591January 1, 2025
Tolvaptan (Jynarque) (PDF)CP.PHAR.27October 1, 2024
Topotecan (Hycamtin) (PDF)CP.PHAR.64July 1, 2024
Topical Acne Treatment (PDF)HIM.PA.71January 1, 2025
Topical Immunomodulators (PDF)CP.PMN.107February 1, 2024
Topiramate ER (Qudexy XR, Trokendi XR (PDF)CP.PMN.281October 1, 2024
Toripalimab-tpzi (Loqtorzi) (PDF)CP.PHAR.668July 1, 2024
Tovorafenib (Ojemda) (PDF)CP.PHAR.686November 1, 2024
Trabectedin (Yondelis) (PDF)CP.PHAR.204February 1, 2024
Tralokinumab-ldrm (Adbry) (PDF)CP.PHAR.577November 1, 2024
Trametinib (Mekinist) (PDF)CP.PHAR.240July 1, 2024
Trastuzumab (Herceptin), Trastuzumab-dkst (Ogivri) (PDF)CP.PHAR.228August 1, 2024
Travoprost (iDose TR) (PDF)CP.PHAR.672August 1, 2024
Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612Retire by December 1, 2024
Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612December 1, 2024
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF)CP.PHAR.199February 1, 2024
Triamcinolone ER Injection (Zilretta) (PDF)CP.PHAR.371September 1, 2024
Triclabendazole (Egaten) (PDF)CP.PMN.207September 1, 2024
Trientine (Syprine) (PDF)CP.PHAR.438January 1, 2025
Trifarotene (Aklief) (PDF)CP.PMN.225February 1, 2024
Trifluridine/Tipiracil (Lonsurf) (PDF)CP.PHAR.383September 1, 2024
Triheptanoin (Dojolvi) ^ (PDF)CP.PHAR.509January 1, 2025
Triptorelin pamoate (Trelstar®, Triptodur®) (PDF)CP.PHAR.175January 1, 2025
Trofinetide (Daybue) (PDF)CP.PHAR.600June 1, 2024
Tucatinib (Tukysa) (PDF)CP.PHAR.497October 1, 2024
Ublituximab-xiiy (Briumvi) (PDF)CP.PHAR.621June 1, 2024
Ubrogepant (Ubrelvy) (PDF)CP.PHAR.476March 1, 2022
Udenafil (PDF)CP.PHAR.557December 1, 2023
Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF)CP.PMN.277January 1, 2025
Umbralisib (Ukoniq) (PDF)CP.PHAR.531July 1, 2024
Uridine acetate (Vistogard) (PDF)HIM.PA.SP55January 1, 2025
Vadadustat (Vafseo) (PDF)CP.PHAR.677August 1, 2024
Valbenazine (Ingrezza) (PDF)CP.PCH.48August 1, 2024
valganciclovir (Valcyte) (PDF)CP.PCH.06April 1, 2024
Valoctocogene Roxaparvovec (PDF)CP.PHAR.466April 1, 2024 (Previously Pending FDA Approval)
Valrubicin (Valstar) (PDF)CP.PHAR.439March 1, 2025
Valrubicin (Valstar) (PDF)CP.PHAR.439Retire by March 1, 2025
Vamorolone (Agamree) (PDF)CP.PHAR.659February 1, 2024
Vandetanib (Caprelsa®) (PDF)CP.PHAR.80February 1, 2024
Varenicline (Tyrvaya) (PDF)CP.PMN.273March 1, 2025
Varenicline (Tyrvaya) (PDF)CP.PMN.273Retire by March 1, 2025
Velaglucerase Alfa (VPRIV) (PDF)CP.PHAR.163June 1, 2024
Velmanase Alfa-tycv (Lamzede) (PDF)CP.PHAR.601June 1, 2024
Vemurafenib (Zelboraf®) (PDF)CP.PHAR.91February 1, 2024
Venetoclax (Venclexta) (PDF)CP.PHAR.129January 1, 2025
Vestronidase alfa-vjbk (Mepsevii) (PDF)CP.PHAR.374July 1, 2024
Verteporfin (PDF)CP.PHAR.187February 1, 2024
Vigabatrin (Sabril) (PDF)CP.PHAR.169September 1, 2024
Vilazodone (Viibryd) (PDF)CP.PMN.145July 1, 2021
Viloxazine (Qelbree) (PDF)CP.PMN.264June 1, 2024
Viltolarsen (Viltepso) (PDF)CP.PHAR.484April 1, 2024
Vincristine Liposome (Marqibo®) (PDF)CP.PHAR.315Retire by January 1, 2025
Vismodegib (Erivedge) (PDF)CP.PHAR.273July 1, 2024
Vutrisiran (Amvuttra)CP.PHAR.550July 1, 2024
Voclosporin (Lupkynis) (PDF)CP.PHAR.504July 1, 2024
Vorapaxar (Zontivity) (PDF)HIM.PA.146February 1, 2024
Vorasidenib (Voranigo) (PDF)CP.PHAR.699January 1, 2025
Voretigene neparvovec-rzyl (Luxturna) (PDF)CP.PHAR.372February 1, 2024
Vorinostat (Zolinza) (PDF)CP.PHAR.83September 1, 2024
Vortioxetine (Trintellix®) (PDF)CP.PMN.65October 1, 2024
Voxelotor (Oxbryta) (PDF)CP.PHAR.451January 1. 2025
Voxelotor (Oxbryta) (PDF)CP.PHAR.451Retire by January 1. 2025
Zanubrutinib (Brukinsa) (PDF)CP.PHAR.467August 1, 2024
Zavegepant (Zavzpret) (PDF)CP.PHAR.630March 1, 2025
Zavegepant (Zavzpret) (PDF)CP.PHAR.630Retire by March 1, 2025
Zilucoplan (RA101495) (PDF)CP.PHAR.616February 1, 2024
Ziv-aflibercept (Zaltrap®) (PDF)CP.PHAR.325January 1, 2025
Zoledronic acid (PDF)CP.PHAR.59February 1, 2024
Zuranolone (Zurzuvae) (PDF)CP.PHAR.650June 1, 2024